Home> #BIGDATAFORBLOODCANCER campaign for clinicians and researchers: April - July 2021.> 4. Supporting doctors in their decision making

4. Supporting doctors in their decision making

May 28, 2021 10:50 - x 00, 0 - 00:00

HARMONY demonstrates the power of Big Data analytics to inform personalized medicine in blood cancer. By pooling data of thousands of patients, HARMONY researchers will be able to study combinations of prognostic factors, for instance minimal residual disease in combination with genetic profile. This may allow researchers to more precisely predict clinical course and drug response, enabling physicians to rapidly select the most promising and least toxic treatment for a particular patient.

Excellent scientists and clinicians, who have contributed to the understanding of the complex nature of these diseases, work together in HARMONY. They initiate unique projects, will give examples of successful implementations of precision diagnostics and targeted therapies, and will discuss what we can expect in the future.

Read the #Bigdataforbloodcancer Blog: Balance between Big Data and Cybersecurity, with a real impact on patients with Hematological tumors >

by HARMONY Partners: Dr. Guillermo Sanz, Head of the Clinical Hematology Section at Hospital Universitario La Fe from Valencia and HARMONY Co-Chair and Dr. Jesús María Hernández Rivas, specialist of the Hematology Service of the University Hospital of Salamanca and HARMONY Coordinator.

Read the #Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach >

by HARMONY Partners: Professor Richard Rosenquist Brandell, Professor of Clinical Genetics at Karolinska Institutet and director of Genomic Medicine Sweden; Professor Lars Bullinger, Director of the Medical Department of Hematology, Oncology, and Tumorimmunology of the Charité Universitätsmedizin Berlin; Professor Kimmo Porkka, Head Hematology Division/HUCH of the University of Helsinki; Professor Caroline Heckman, Research Director at the Institute for Molecular Medicine Finland (FIMM) of the University of Helsinki.

Meet the HARMONY Patient Cluster: A unique group of 9 European Patient Umbrella Organizations working in the different areas of hematological diseases within the HARMONY Alliance >

The Patient Cluster and their patient communities are consistently involved in the definition of outcomes, the design of Research Projects and the information of patients. In addition the Patient Cluster also make sure that there is a reliable bi-directional flow of information within and outside of the Alliance. For the first time in a major research project, the patient community sits at the table as truly equal partners to researchers, industry and regulators. 

How can HARMONY help doctors to make the right decisions when treating blood cancer patients?


Listen to Tamás Bereczky from HARMONY Partner Leukanet

What is the role of Patient Organizations in HARMONY?

Listen to Solène Clavreul, Myeloma Patients Europe.

Receive the latest news. Click here to subscribe!